The CORE update for October 15, 2026

The CORE update lists 15 outbreaks and adverse event postings. For the Listeria monocytogenes outbreak (ref #1415), FDA has initiated sample collection. For the E. coli O26:H11 outbreak (ref #1419) linked to raw milk cheese, the outbreak advisory was updated on October 9, 2026, to include international distribution information. FDA has initiated sample collection. This outbreak is associated with 13 illnesses, 8 hospitalizations, and 3 HUS. For the E. coli O157:H7 outbreak (ref #1421) linked to multi-ingredient chicken wraps, the case count has increased from 38 to 50. For the Listeria monocytogenes outbreak (ref #1417), the case count increased from 44 to 46. For the Salmonella bovis morbillis outbreak (ref #1411), FDA updated the outbreak advisory with downstream product recalls and sampling information. The outbreak is associated with 32 illnesses and 3 hospitalizations. For the Cyclospora outbreak (ref #1392), the case count has been adjusted from 235 to 240. The outbreak of Salmonella Oranienburg (ref #1387) has ended. For the outbreak of Salmonella Enteritidis (ref #1378) linked to shell eggs, the Executive Incident Summary Abstract can now be accessed by clicking the reference number. This outbreak investigation was moved to the Closed 2026 Table. On 9/3/2026, CDC closed the epidemiologic investigation with 134 cases from 18 states: AR (5), AZ (4), CA (1), CO (1), GA (2), IL (1), LA (8), MI (1), MO (1), MS (1), NC (1), NM (3), NV (1), NY (1), OK (2), SC (1), TX (99), and WV (1). There were 34 hospitalizations. For the Salmonella Typhimurium outbreak in Newport and Richmond (ref #1358) linked to moringa leaf powder, the Executive Incident Summary Abstract can now be accessed by clicking the reference number. At the close of this incident, the outbreak included 131 cases (Newport (3), Richmond (1), and Typhimurium (127)) across 38 states, with 36 hospitalizations and zero deaths reported. This outbreak investigation was moved to the Closed 2026 Table. For the outbreak of Clostridium botulinum (ref #1383) linked to infant formula, the Executive Incident Summary Abstract can now be accessed by clicking the reference number. This outbreak investigation was moved to the Closed 2026 Table. @ https://www.fda.gov/food/outbreaks-foodborne-illness/investigations-foodborne-illness-outbreaks?utm_medium=email&utm_source=govdelivery

 

 

 Investigations of Foodborne Illness Outbreaks
Investigations of Foodborne Illness Outbreaks

The following is a list of outbreak and adverse event investigations primarily being managed by FDA’s CORE Response Teams.

No comments

Leave a Reply